藥明康德(02359.HK)股東因違反承諾減持致歉
藥明康德(02359.HK)(603259.SH)公布,於上周五(11日)收到公司股東上海瀛翊投資中心通知及致歉,指上海瀛翊於5月14日至6月8日期間,通過上海證券交易所集中競價交易系統減持公司合共近1,724.97萬股A股股份,佔公司總股本約0.6962%,減持價格區間為每股143.49至176.88元人民幣(下同),總金額為28.94億元。
由於上海瀛翊在實施本次減持之前未能遵守其作為委托投票方作出的有關減持公司股份的相關承諾,未提前通知公司,也沒有提前15個交易日通過公司披露減持計劃履行公告等相關程序,違反減持承諾。
公司表示,上海瀛翊自查確認上述違反承諾的減持行為後,已立即停止減持行為,並已責令相關人員學習相關法律、法規,以杜絕此類事件再次發生。截至目前,上海瀛翊持有藥明康德417.46萬股A股股份,佔公司總股本約0.1419%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.